u.s fda woes for sun pharma, gets 6 observations for mohali plant | business lunch | cnbc-tv18
Published 2 years ago • 712 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
23:49
us fda issues 6 observation on sun pharma | halftime report | cnbc-tv18
-
1:53
sun pharma’s mohali unit receives observations from us fda
-
1:55
sun pharma mohali unit: u.s. fda flags compliance concerns | halftime report | cnbc-tv18
-
1:18
us fda records 11 observations for sun pharma’s dadra facility
-
2:16
sun pharma's halol facility receives u.s. fda warning letter | business lunch | cnbc-tv18
-
1:23
us fda lifts ban on sun pharma's mohali plant
-
2:36
u.s. fda issues warning letter to sun pharma, questions manufacturing practices at halol facility
-
2:47
sun pharma halol plant | us fda issues 3 observations in form 483 | cnbc tv18
-
3:06
sun pharma receives warning letter from us fda for its halol plant
-
2:29
us fda finds incomplete lab records for sun pharma's dadra unit
-
0:47
#shorts | sun pharma shares tank after us fda issues 10 observations to its halol facility
-
1:24
sun pharma gets us fda approval for zetia generic
-
2:38
relief for sun pharma: us fda clears sun pharma's dadra unit
-
2:33
zydus life dips over 5% after teva gets us fda approval for asacol hd generic | cnbc tv18
-
3:56
sun pharma news: u.s. fda lists company's halol plant under an import alert | halftime report
-
2:00
zydus under pressure after teva gets us fda approval for asacol hd generic | cnbc tv18
-
5:10
vishal manchanda on impact of u.s fda oai status on sun pharma | bazaar open exchange | cnbc-tv18
-
2:13
us fda woes haunt sun pharma?
-
2:20
boost for sun pharma | u.s.fda nod for 1st product from halol | cnbc tv18